Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This prospective randomized, open-label, multicenter, phase II clinical trial investigates the safety and tolerability of standard neoadjuvant chemoradiotherapy (CRT) with sequential ipilimumab and nivolumab in rectal cancer.
Epistemonikos ID: 162a8b6c6481f61f3489982b1ed14031cb638c1e
First added on: May 22, 2024